CLINICAL CANCER RESEARCH（临床癌症研究杂志）影响因子_期刊投稿发表

期刊简介

Clinical Cancer Research publishes innovative clinical and translational cancer research studies that bridge the laboratory and the clinic. The Journal is especially interested in clinical trials evaluating new treatments, accompanied by research on pharmacology, and molecular alterations or biomarkers that predict response or resistance to treatment. The Journal also prioritizes laboratory and animal studies of new drugs and molecule-targeted agents with the potential to lead to clinical trials, and studies of targetable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease.Specific areas of interest include clinical and translational research in targeted therapies; mechanisms of drug sensitivity and resistance; pharmacogenetics and pharmacogenomics; personalized medicine; novel applications of bioinformatics and biostatistics; immunotherapy and clinical immunology; gene therapy; radiobiology and radiation oncology; large-scale molecular characterization of human tumors; diagnostic biomarkers; innovative imaging and other novel methods with potential applicability to clinical investigation; clinical genetics; and detection of minimal disease.

临床癌症研究出版创新的临床和转化癌症研究的研究，桥梁实验室和临床。该杂志对评估新疗法的临床试验特别感兴趣，同时对药理学、预测治疗反应或耐药性的分子变化或生物标志物进行研究。该杂志还优先考虑新药和分子靶向制剂的实验室和动物研究，有可能导致临床试验，以及肿瘤发生、恶性表型进展和转移性疾病的靶向机制研究。药物敏感和耐药机制;药物遗传学和药物基因组学;个性化医疗;生物信息学和生物统计学的新应用;免疫治疗和临床免疫学;基因治疗;放射生物学和放射肿瘤学;人类肿瘤的大规模分子表征;诊断性生物标志物;具有潜在临床研究适用性的创新成像和其他新方法;临床遗传学;和微小疾病检测。

《CLINICAL CANCER RESEARCH》期刊已被查看：次

分区信息